Semax for Focus, Mood, and Brain Health: What the Research Actually Shows

Semax is often discussed alongside Selank, and many biohackers use them together. While Selank is primarily anxiolytic, Semax is primarily nootropic, meaning it targets cognitive enhancement. Like Selank, it was developed in Russia and has regulatory approval there, but lacks FDA evaluation.

What Is Semax?

Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Its amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed at the Russian Academy of Sciences and is used clinically in Russia for stroke, cognitive disorders, peptic ulcers, optic nerve disease, and immune support.

The key design principle of Semax was to retain the neuroprotective and cognitive-enhancing effects of ACTH fragments while eliminating hormonal side effects. The modification with Pro-Gly-Pro extended its duration of action from minutes to 20-24 hours in animal models.

Semax is on the Russian List of Vital and Essential Drugs and has undergone extensive study there. However, it has not been evaluated, approved for use, or marketed in most other countries.

How Semax Works

BDNF enhancement:

Semax increases levels of brain-derived neurotrophic factor (BDNF), a protein essential for neuroplasticity, learning, and memory formation. BDNF supports the growth and survival of neurons and the formation of new synaptic connections. Low BDNF levels have been associated with depression and cognitive decline. By enhancing BDNF, Semax may support both cognitive function and mood.

Neurotransmitter modulation:

Semax enhances the release and balance of dopamine and serotonin, promoting motivation, mood stability, and mental drive. It may also affect the brain’s serotoninergic system, contributing to its neuroprotective effects.

Gene expression:

Research shows Semax modulates over 1,500 genes, particularly those involved in immune and vascular system function. This broad effect profile may explain its diverse applications.

The Evidence

Cognitive effects in healthy people:

One study examined intranasal Semax in healthy but fatigued volunteers after 8-hour work shifts. Following a single dose of 16 mcg/kg, participants demonstrated a 71 percent accuracy rate on a memory test, compared to 41 percent in the control group. Effects lasted 24 hours.

Stroke recovery:

In a trial involving 110 stroke patients, intranasal Semax (two 10-day courses of 6000 mcg/day) increased plasma BDNF levels. Patients with high BDNF levels showed improved timing of rehabilitation. Another study in acute stroke patients demonstrated significant anti-inflammatory benefits.

Anxiolytic and antidepressant effects:

In animal models, Semax normalized disrupted behavior caused by anxiety-inducing compounds, suggesting potential anxiolytic and antidepressant effects when stress levels are elevated. It had no effect on rats in their normal state, suggesting it may be most relevant for stressed or impaired states.

Limitations:

Published English-language studies with well-conducted methodology are limited. Most detailed evidence comes from Russian literature that is difficult to fully evaluate. Long-term safety data and interaction studies with psychiatric medications are lacking.

Semax and Selank Together

Many biohackers use Semax and Selank as a combined protocol. The rationale is complementary mechanisms: Selank for anxiety reduction, Semax for cognitive enhancement. Both share certain properties, including enkephalin preservation.

There is no clinical trial data on the combination. The practice is based on theoretical complementarity and user experience rather than rigorous evidence. That said, both peptides appear to have favorable safety profiles individually, and no obvious interaction concerns have emerged.

Practical Considerations

Administration:

Semax is typically administered as a nasal spray or subcutaneous injection. Nasal administration is most common for nootropic use.

Dosing:

Dosing varies widely in the literature and biohacking community. Russian clinical applications range from 200 mcg to 20,000 mcg daily depending on indication. For cognitive enhancement, doses of 200-1000 mcg daily are commonly reported. There is no established optimal dose for mental health applications.

Potential side effects:

Some users report increased anxiety, particularly at higher doses. This may relate to its stimulant-like effects on cognition. As with Selank, hair thinning has been anecdotally reported, possibly related to BDNF modulation, though this is unconfirmed.

My Clinical Perspective

Semax is interesting for patients struggling with cognitive symptoms of depression, brain fog, or mental fatigue. Its BDNF-enhancing mechanism aligns with what we know about neuroplasticity and recovery from stress.

The evidence is stronger for cognitive effects than for mood effects specifically. If a patient’s primary complaint is depression, Semax would not be my first consideration. If they are experiencing cognitive dulling alongside mood symptoms, or recovering from a period of high stress, the rationale is more compelling.

As with all peptides in this series, the evidence does not meet the standard for treatment recommendation. I help patients who choose to use it understand what they are taking and monitor for problems.